<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02828579</url>
  </required_header>
  <id_info>
    <org_study_id>JagiellonianU-04</org_study_id>
    <nct_id>NCT02828579</nct_id>
  </id_info>
  <brief_title>The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease</brief_title>
  <official_title>The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jagiellonian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jagiellonian University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Up to 300 million people have a BMI over 30kg/m2. Obesity is the cause of many serious
      diseases, such as type 2 diabetes, hypertension and NAFLD. Bariatric surgery is the only
      effective method of achieving weight loss in patients with morbid obesity.

      The aim of the study is to assess the impact of bariatric surgery on non-alcoholic fatty
      liver disease in patients operated on due to morbid obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators include 20 patients qualified for the bariatric procedure with BMI &gt; 40 kg/m2
      or a BMI &gt; 35kg/m2 with the presence of comorbidities. The average body weight in the group
      was 143.85kg with an average BMI of 49.16kg/m2. Before the procedure, investigators evaluated
      the severity of the non-alcoholic fatty liver disease in each patient using the Sherif Saadeh
      ultrasound scale. Investigators also evaluated the levels of the liver enzymes. Follow up was
      performed twelve months after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NAFLD</measure>
    <time_frame>12 months</time_frame>
    <description>Ultrasound assessment of the severity of NAFLD with the Sherif-Saadeh scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight loss after bariatric surgery</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Excess Body Mass Index loss (EBMIL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comorbidities</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Number of patients with hypertension and diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver function impairment</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Standard set of blood liver enzymes including aspartate aminotransferase (AST) and alanine aminotransferase (ALT)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Obesity</condition>
  <condition>NAFLD</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patient with morbid obesity defined as a BMI above 40kg/m2 or 35kg/m2 with comorbidities who are qualified for bariatric surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bariatric surgery</intervention_name>
    <description>Laparoscopic Sleeve Gastrectomy (LSG) Laparoscopic Roux-en-Y Gastric Bypass (LRYGB)</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The analysis included prospectively collected data from consecutive patients electively
        operated for morbid obesity in 2015.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients at the age of 18-60, meeting the criteria of qualification for the surgical
        treatment of obesity, i.e. BMI &gt; 40 kg/m2 or BMI &gt; 35 kg/m2 together with accompanying
        diseases.

        Exclusion Criteria:

          -  chronic mental diseases

          -  addictions

          -  earlier bariatric procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piotr Major, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>2'nd Department of General Surgery, Jagiellonian University Medical College</affiliation>
  </overall_official>
  <results_reference>
    <citation>Pirvulescu I, Gheorghe L, Csiki I, Becheanu G, Dumbravă M, Fica S, Martin S, Sarbu A, Gheorghe C, Diculescu M, Copăescu C. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. Chirurgia (Bucur). 2012 Nov-Dec;107(6):772-9.</citation>
    <PMID>23294957</PMID>
  </results_reference>
  <results_reference>
    <citation>Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002 Sep;123(3):745-50.</citation>
    <PMID>12198701</PMID>
  </results_reference>
  <results_reference>
    <citation>Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Review.</citation>
    <PMID>19726018</PMID>
  </results_reference>
  <results_reference>
    <citation>Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, Dai F, Li F, Chen SY. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol. 2005 Dec;20(12):1825-32.</citation>
    <PMID>16336439</PMID>
  </results_reference>
  <results_reference>
    <citation>Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010 Jan;51(1):121-9. doi: 10.1002/hep.23276.</citation>
    <PMID>19827166</PMID>
  </results_reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2016</study_first_submitted>
  <study_first_submitted_qc>July 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2016</study_first_posted>
  <last_update_submitted>July 8, 2016</last_update_submitted>
  <last_update_submitted_qc>July 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jagiellonian University</investigator_affiliation>
    <investigator_full_name>Michał Pędziwiatr</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>bariatric surgery</keyword>
  <keyword>non-alcoholic fatty liver disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>data not entered</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

